TP-100 Testosterone Propionate 100mg/ml Oil Steroids Injectable

Description

Testosterone Propionate Short-Ester Injectable Androgen Research

Overview

Testosterone Propionate is a synthetic 17β-hydroxyandrost-4-en-3-one propionate analogue designed for high-frequency physiological activity via a short-chain carboxylic acid ester delivery system. Testosterone Propionate activates nuclear androgen receptors to initiate genomic signaling pathways critical for myogenic repair and protein synthesis. Researchers prioritize this parenteral oil-based matrix for investigating acute metabolic flux and rapid receptor saturation in advanced biological models. By utilizing a propionate ester, this compound ensures rapid systemic bioavailability compared to longer-chain testosterone versions.

Molecular Data

• CAS Number: 57-85-2
• Molecular Formula: C22H32O3
• Molecular Weight: 344.49 g/mol
• Appearance: Clear to pale straw viscous lipid solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids like Grapeseed Oil or Miglyol 840

Pharmacodynamics

The pharmacology of Testosterone Propionate is defined by its rapid ester-cleavage kinetics and robust receptor binding. Intramuscular esterases cleave the propionate chain to liberate the parent testosterone molecule into systemic circulation. The free androgen ligand binds to cytoplasmic androgen receptors, facilitating the translocation of the receptor complex into the cell nucleus. Androgen receptor activation triggers RNA polymerase activity, which accelerates the synthesis of contractile proteins and enhances nitrogen retention. Binding kinetics show a high affinity for the AR with a Ki value of approximately 0.5 to 1.2 nM. Quantitatively, the terminal half-life is approximately 19 to 36 hours (±6 hours) in healthy research subjects. Compared to Test Enanthate, the propionate ester provides a significantly narrower pharmacokinetic window, allowing for more precise control over androgen levels but requiring more frequent titration.

Experimental Outcomes

• Acute Myofibrillar Hypertrophy: Study findings show rapid increases in muscle density and visual hardness during short-term research phases.
• Erythropoietic Stimulation: Based on community feedback, effects include a marked increase in red blood cell production, improving oxygen transport.
• Lipolytic Pathway Activation: Published research indicates improved nutrient partitioning and accelerated fat loss in calorie-restricted research models.
• Positive Nitrogen Flux: Observed effects include a 40-50% improvement in nitrogen retention compared to baseline controls in metabolic studies.
• Neurological Force Production: Research models indicate a sharp upward trajectory in maximal strength and central nervous system (CNS) drive.

Summary:
Testosterone Propionate remains a high-precision research tool for studying acute androgenic signaling and myogenic regulatory factors with rapid pharmacokinetic clearance.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.